Chief Strategy Officer

Weidong Zhong

Weidong is an accomplished R&D executive and successful biotech entrepreneur with nearly 30 years of industrial experience and a proven track record in drug discovery and development across multiple therapeutic areas, delivering dozens of small-molecule and biologic drug candidates to clinical development including marketing authorizations. Most recently, Weidong was President and Chief Strategy Officer of Sciwind Biosciences where he oversaw global development and corporate partnerships. Previously, he was the founder, CEO and Chief Scientific Officer of Terns Pharmaceuticals, a biotech company focusing on liver and metabolic diseases, Global Head of Antiviral Research at Novartis, and Senior Director of Biology at Gilead Sciences where he led research efforts in viral hepatitis and liver fibrosis. During early years of his career, Weidong held research leadership positions of increasing responsibilities at Schering-Plough Research Institute, Valeant and SmithKline Beecham. 

Weidong received his Ph.D. in Biochemistry from the University of Wisconsin-Madison and did postdoctoral research at University of California-San Francisco.